News Conference News TCT 2020 Under ISCHEMIA’s Long Shadow, Cardiologists Ponder Shifting Guidelines, Care Michael O'Riordan October 19, 2020
News Conference News TCT 2020 Bivalirudin vs Heparin Patient-Level Meta-analysis Stirs an Old Debate Shelley Wood October 14, 2020
News Conference News EAS 2020 Just One-Third of European Patients Get to LDL Cholesterol Goals Michael O'Riordan October 13, 2020
News Conference News EAS 2020 Inclisiran Effective Across FH Genotypes, as Well as in Primary Prevention Michael O'Riordan October 08, 2020
News Conference News EAS 2020 Lp(a) and LPA Genetic Risk Score Both Predict Incident ASCVD: UK Biobank Michael O'Riordan October 07, 2020
News Daily News Uptick in Heparin-Induced Thrombocytopenia in COVID-19 Complicates Care Michael O'Riordan October 02, 2020
News Opinion Editor's Corner TCTMD’s Top 10 Most Popular Stories for September 2020 Shelley Wood October 01, 2020
News Daily News Even in Ideal Patients, Surgeons Aren’t Doing Multiarterial CABG Shelley Wood September 28, 2020
News Daily News Increased Lifetime Exposure to High LDL Cholesterol Predicts ASCVD Michael O'Riordan September 22, 2020
News Daily News Hostility After ACS Linked to All-Cause Mortality Michael O'Riordan September 21, 2020
News Daily News ‘Aspirin-Free’ Antiplatelet Strategy Feasible After PCI, Pilot Study Suggests Michael O'Riordan September 18, 2020
News Daily News ‘Speaking the Same Language’: New Guidance for Trials of Patients at High Bleeding Risk Michael O'Riordan September 16, 2020
News Conference News Blood Pressure Insights in COVID-19: Watch for Drops and RAAS Red Flags L.A. McKeown September 10, 2020
News Daily News Barriers to Flu Shot in ASCVD Patients: Age, Race, Healthcare Access Caitlin E. Cox September 09, 2020
News Conference News ESC 2020 New European NSTE ACS Guidelines Embrace hs-Troponin, CTA, NOAC Trials Caitlin E. Cox September 03, 2020
News Daily News Free CAC Scans for ASCVD Risk Capture More Women, Minorities, and Low-Income Adults Michael O'Riordan September 02, 2020
News Conference News ESC 2020 ACE Inhibitors, ARBs Pose No Risk in COVID-19: BRACE CORONA Michael O'Riordan September 01, 2020